VBI Vaccines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VBI Vaccines and buy or sell other stocks, ETFs, and their options commission-free!About VBIV
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601.
CEOJeff Baxter
CEOJeff Baxter
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1965
Founded1965
Employees—
Employees—
VBIV Key Statistics
Market cap14.30K
Market cap14.30K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume30.72K
Average volume30.72K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0505
52 Week high$0.0505
52 Week low—
52 Week low—
Stock Snapshot
VBI Vaccines(VBIV) stock is priced at $0.65, giving the company a market capitalization of 14.3K.
VBI Vaccines(VBIV) stock opened on 2025-11-21 at —. The price climbed to — and dipped to —.
The VBI Vaccines(VBIV)'s current trading volume is 0, compared to an average daily volume of 30.72K.
People also own
Based on the portfolios of people who own VBIV. This list is generated using Robinhood data, and it’s not a recommendation.